Early signs of Vitamin B12 deficiency neuropathy: A clinical report on neurological manifestations

Vitamin B12 deficiency is frequently linked to a broad spectrum of progressive neurologic syndromes, making early identification essential for preventing potentially permanent damage 1. While often associated with hematological issues, neurological impairment can occur independently, manifesting as peripheral neuropathy, myelopathy, or cognitive disturbance 1. Recognizing these subtle indicators in primary care settings is a critical component of diagnostic investigation 8. Given that early-stage cases frequently remain undiagnosed, understanding the clinical trajectory of this deficiency is vital for patient outcomes 3.

Common Clinical Presentations

Patients with vitamin B12 deficiency neuropathy often present with symmetrical sensory changes, frequently described as a stocking-glove distribution 9. This pattern is characterized by tingling, numbness, or burning pain that primarily affects the distal extremities 9. These sensations, often referred to as paresthesia or pins and needles, serve as a frequent initial neurological manifestation 2. In addition to these sensory changes, individuals may report impaired vibration sense and reduced ankle reflexes, which are standard metrics during clinical evaluations for peripheral neuropathy 9.

Subclinical Small Fiber Neuropathy

Recent research highlights that vitamin B12 deficiency is a significant risk factor for small fiber neuropathy, a condition that affects thinly myelinated and unmyelinated fibers 3. Because these fibers are small, their initial degradation often remains undetectable in standard nerve conduction studies 6. To address this, clinical investigations have increasingly utilized specialized techniques, such as sympathetic skin response (SSR) and cutaneous silent period (CSP) recordings, to evaluate the autonomic and somatic function of these fibers in patients who show nonspecific complaints despite normal baseline testing 3.

Pathophysiological Mechanisms

The neurological consequences of vitamin B12 deficiency are deeply rooted in the vitamin's role in cellular metabolism. Cobalamin, the active form of vitamin B12, is essential for nucleic acid metabolism, methyl transfer, and critically, the synthesis and repair of myelin 2. Myelin acts as the protective sheath for nerve fibers; its degradation-specifically in the white matter of the spinal cord and peripheral nerves-is the primary driver of the neurological decline observed in these patients 2. This disruption leads to the loss of proprioception and balance, manifesting as gait ataxia 4.

Diagnostic Considerations and Complexity

Diagnostic investigation for B12 deficiency is frequently complicated by the fact that routine laboratory tests may not always reflect the true clinical status of a patient 8. While total serum B12 is the standard initial measurement, values in the borderline range of 180 to 350 pg/mL often necessitate further analysis, such as serum methylmalonic acid testing, to confirm a physiological deficiency 4. Abnormal red blood cell indices are notably neither sensitive nor specific for identifying B12-related nerve damage, reinforcing the need for direct B12 or metabolite testing 1.

Risk Factors and Vulnerable Populations

Vitamin B12 deficiency affects approximately 2% to 3% of adults in the United States, with risk increasing among older populations and those with specific malabsorptive conditions 4. Medications such as metformin and proton pump inhibitors are known to interfere with nutrient absorption, potentially increasing the risk of deficiency in patients managing long-term health conditions 5. Furthermore, those following strict vegan diets without supplementation are at an increased risk, as dietary B12 is primarily found in animal products like meat, eggs, and dairy 2.

The Necessity of Timely Intervention

The clinical course of vitamin B12 deficiency neuropathy can be stabilized or even reversed with appropriate therapeutic intervention, provided it is initiated before structural nerve damage becomes irreversible 7. Treatment typically involves oral or parenteral B12 therapy, with recent evidence suggesting that high-dose oral supplementation is as effective as injection therapy for many patients 1. It is imperative to avoid using folate monotherapy, as it may mask hematological anemia while failing to halt the progression of neurological deficits, thus delaying necessary care 2.

Sources

1. Lanska DJ. Vitamin B12 deficiency. MedLink Neurology. Updated 2025.
2. Johnson LE. Vitamin B12 deficiency. MSD Manual Professional Edition. Updated 2026.
3. Issi ES. Assessment of possible small fiber neuropathy in early-stage vitamin B12 deficiency. Arq Neuro-Psiquiatr. 2025.
4. Patel H, McGuirk R. Vitamin B12 deficiency: Common questions and answers. American Family Physician. 2025.
5. Current Nutrition Reports. B vitamin deficiencies and associated neuropathies. Springer Nature. 2026.
6. Arquivos de Neuro-Psiquiatria. Thieme E-Journals full text. 2025.
7. The Egyptian Journal of Internal Medicine. Non-hematological manifestations of vitamin B12 deficiency. Springer Nature. 2026.
8. Varon M, et al. Nutrition-related peripheral neuropathies. MedLink Neurology. 2026.
9. Moore E. Diagnostic algorithms for the investigation of disorders of vitamin B12. Journal of Laboratory and Precision Medicine. 2026.
10. Tytler K. Peripheral neuropathy: Stocking-glove pattern. NICE NG127. 2026.